Simultaneous determination of acetylsalicylic acid and salicylic acid in human plasma by high-performance liquid chromatography.
A high-performance liquid chromatographic (HPLC) method is described for the simultaneous determination of acetylsalicylic acid (ASA) and its main metabolite salicylic acid (SA) in human plasma. Acidified plasma is deproteinized with acetonitrile which is separated from the aqueous layer by adding sodium chloride. ASA and SA are extracted into the acetonitrile layer with high yield, and determined by reversed-phase HPLC (column: Novapak C18 4 microns silica, 150 x 4 mm I.D.; eluent: 740 ml water, 900 microliters 85% orthophosphoric acid, 180 ml acetonitrile) and photometric detection (237 nm). 2-Methylbenzoic acid is used as internal standard. The method allows the determination of ASA and SA in human plasma as low as 100 ng/ml with good precision (better than 10%). The assay was used to determine the pharmacokinetic parameters of ASA and SA following oral administration of 100-500 mg ASA in healthy volunteers.
Kees
F
F
Department of Pharmacology, University of Regensburg, Germany.
Jehnich
D
D
Grobecker
H
H
D018712:Analgesics, Non-Narcotic / Q000097:blood* / Q000493:pharmacokinetics; D001241:Aspirin / Q000097:blood* / Q000493:pharmacokinetics; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D007202:Indicators and Reagents; D011786:Quality Control; D015203:Reproducibility of Results; D012459:Salicylates / Q000097:blood*; D020156:Salicylic Acid; D013048:Specimen Handling; D013810:Therapeutic Equivalency
D018712:Analgesics, Non-Narcotic; D007202:Indicators and Reagents; D012459:Salicylates; D020156:Salicylic Acid; D001241:Aspirin